Clinical review: Idiopathic pulmonary fibrosis acute exacerbations - Unravelling Ariadne's thread

Critical Care

Volumn 14, Issue 6, 2010, Pages

  Papiris, Spyros A ^a   Manali, Effrosyni D ^a   Kolilekas, Likurgos ^a   Kagouridis, Konstantinos ^a   Triantafillidou, Christina ^a   Tsangaris, Iraklis ^a   Roussos, Charis ^b,c  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 8;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL ASSESSMENT; DIFFUSE ALVEOLAR DAMAGE; DISEASE EXACERBATION; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; LUNG ANGIOGRAPHY; LUNG DISEASE; LUNG LAVAGE; LUNG TRANSPLANTATION; OXYGEN TENSION; PALLIATIVE THERAPY; PHYSICAL EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY; ACUTE DISEASE; ANIMAL; METHODOLOGY; PATHOPHYSIOLOGY;

ACUTE DISEASE; ACUTE LUNG INJURY; ANIMALS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTENSIVE CARE UNITS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 79955478924     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9241     Document Type: Review

References (75)

1. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Thoracic Society/European Respiratory Society, Am J Respir Crit Care Med 2002 165 277 304 11790668
2. Interstitial lung disease guideline. AU Wells, N Hirani, on behalf of the BTS Group, a subgroup of the British Thoracic Society Standards of Care Committee, in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society, Thorax 2008 63 SUPPL. 5 1 58 10.1136/thx.2008.101691
3. The clinical course of patients with idiopathic pulmonary fibrosis. FJ Martinez, S Safrin, D Weycker, KM Starko, WZ Bradford, TE King Jr, KR Flaherty, DA Schwartz, PW Noble, G Raghu, KK Brown, Ann Intern Med 2005 142 963 967 15968010
4. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. DS Kim, JH Park, BK Park, AG Nicholson, T Colby, Eur Respir J 2006 27 143 150 16387947 10.1183/09031936.06.00114004 (Pubitemid 43092678)
5. Acute exacerbations in idiopathic pulmonary fibrosis. SP Crowley, P Kelly, JJ Egan, Ann Intern Med 2006 144 218 219 16461970
6. Acute exacerbations of idiopathic pulmonary fibrosis. HR Collard, BB Moore, KR Flaherty, KK Brown, RJ Kaner, TE King Jr, JA Lasky, JE Loyd, I Noth, MA Olman, G Raghu, J Roman, JH Ryu, DA Zisman, GW Hunninghake, TV Colby, JJ Egan, DM Hansell, T Johkoh, N Kaminski, DS Kim, Y Kondoh, DA Lynch, J Müller-Quernheim, JL Myers, AG Nicholson, M Selman, GB Toews, AU Wells, FJ Martinez, Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators, Am J Respir Crit Care Med 2007 176 636 643 17585107 10.1164/rccm.200703-463PP (Pubitemid 47503070)
7. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. CE Daniels, ES Yi, JH Ryu, Eur Respir J 2008 32 170 174 18256070 10.1183/09031936.00176307
8. Terminal diff use alveolar damage in relation to interstitial pneumonias. An autopsy study. AJ Rice, AU Wells, D Bouros, RM du Bois, DM Hansell, V Polychronopoulos, D Vassilakis, JR Kerr, TW Evans, AG Nicholson, Am J Clin Pathol 2003 119 709 714 12760290 10.1309/UVARMDY8FE9FJDKU (Pubitemid 37046392)
9. Strategies for treating idiopathic pulmonary fibrosis. RM du Bois, Nat Rev Drug Discov 2010 9 129 140 20094055 10.1038/nrd2958
10. Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosis. BM Elicker, JA Golden, KG Ordovas, L Leard, TR Golden, SR Hays, Respir Med 2010 104 426 433 19913395 10.1016/j.rmed.2009.10.019
11. Current perspectives on the treatment of idiopathic pulmonary fibrosis. N Walter, HR Collard, TE King, Proc Am Thorac Soc 2006 3 330 338 16738197 10.1513/pats.200602-016TK (Pubitemid 43845410)
12. Lung transplantation for idiopathic pulmonary fibrosis. DP Mason, ME Brizzio, JM Alster, AM McNeill, SC Murthy, MM Budev, AC Mehta, OA Minai, GB Pettersson, EH Blackstone, Ann Thorac Surg 2007 84 1121 1128 17888957 10.1016/j.athoracsur.2007.04.096 (Pubitemid 47417865)
13. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. M Selman, G Carrillo, A Estrada, M Mejia, C Becerril, J Cisneros, M Gaxiola, R Prez-Padilla, C Navarro, T Richards, J Dauber, TE King Jr, A Pardo, N Kaminski, PLoS One 2007 2 482 17534432 10.1371/journal.pone.0000482
14. Acute exacerbation of idiopathic pulmonary fibrosis. R Hyzy, S Huang, J Myers, K Flaherty, F Martinez, Chest 2007 132 1652 1658 17998366 10.1378/chest.07-0299 (Pubitemid 350156025)
15. Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease. K Sakamoto, H Taniguchi, Y Kondoh, K Ono, Y Hasegawa, M Kitaichi, Eur Respir Rev 2009 18 129 132 20956132 10.1183/09059180.00000409
16. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Y Kondoh, H Taniguchi, M Kitaichi, T Yokoi, T Johkoh, T Oishi, T Kimura, O Nishiyama, K Kato, RM du Bois, Respir Med 2006 100 1753 1759 16584880 10.1016/j.rmed.2006.02.002 (Pubitemid 44283759)
17. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Y Kondoh, H Taniguchi, Y Kawabata, T Yokoi, K Suzuki, K Takagi, Chest 1993 103 1808 1812 8404104 10.1378/chest.103.6. 1808 (Pubitemid 23174318)
18. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. M Akira, H Hamada, M Sakatani, C Kobayashi, M Nishioka, S Yamamoto, AJR 1997 168 79 83 8976924 (Pubitemid 27014751)
19. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. A Churg, NL Muller, CI Silva, JL Wright, Am J Surg Pathol 2007 31 277 284 17255773 10.1097/01.pas.0000213341. 70852.9d (Pubitemid 46175029)
20. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. M Selman, TE King, A Pardo, Ann Intern Med 2001 134 136 151 11177318 (Pubitemid 32096342)
21. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. M Selman, A Pardo, Proc Am Thorac Soc 2006 3 364 372 16738202 10.1513/pats.200601-003TK (Pubitemid 43845414)
22. New mechanisms of pulmonary fibrosis. RM Strieter, B Mehrad, Chest 2009 136 1364 1370 19892675 10.1378/chest.09-0510
23. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. K Konishi, KF Gibson, KO Lindell, TJ Richards, Y Zhang, R Dhir, M Bisceglia, S Gilbert, SA Yousem, JW Song, DS Kim, N Kaminski, Am J Respir Crit Care Med 2009 180 167 175 19363140 10.1164/rccm.200810-1596OC
24. Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. K Kuwano, Y Nomoto, R Kunitake, N Hagimoto, T Matsuba, Y Nakanishi, N Hara, Eur Respir J 1997 10 1445 1449 9230228 10.1183/09031936.97.10071445 (Pubitemid 27311053)
25. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. RW Tobin, CE Pope, CA Pellegrini, MJ Emond, J Sillery, G Raghu, Am J Respir Crit Care Med 1998 158 1804 1808 9847271 (Pubitemid 29008818)
26. Telomerase mutations in families with idiopathic pulmonary fibrosis. MY Armanios, JJ Chen, JD Cogan, JK Alder, RG Ingersoll, C Markin, WE Lawson, M Xie, I Vulto, JA Phillips, PM Lansdorp, CW Greider, JE Loyd, N Engl J Med 2007 356 1317 1326 17392301 10.1056/NEJMoa066157 (Pubitemid 46513297)
27. Viruses as co-factors for the initiation of exacerbation of lung fibrosis. KM Vannella, BB Moore, Fibrogenesis Tissue Repair 2008 1 2 19014649 10.1186/1755-1536-1-2
28. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. S Blivet, F Philit, JM Sab, B Langevin, M Paret, C Guérin, D Robert, Chest 2001 120 209 212 11451840 10.1378/chest.120.1.209 (Pubitemid 32744881)
29. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. JB Stern, H Mal, O Groussard, O Brugiere, A Marceau, G Jebrak, M Fournier, Chest 2001 120 213 219 11451841 10.1378/chest.120.1.213 (Pubitemid 32744882)
30. Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. T Fumeaux, C Rothmeier, P Jolliet, Intensive Care Med 2001 27 1868 1874 11797021 10.1007/s00134-001-1150-0 (Pubitemid 33145071)
31. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. G Saydain, A Islam, B Afessa, JH Ryu, JP Scott, SG Peters, Am J Respir Crit Care Med 2002 166 839 842 12231494 10.1164/rccm.2104038
32. Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. FM Al-Hameed, S Sharma, Can Respir J 2004 11 117 122 15045042 (Pubitemid 38519170)
33. Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia. L Tiitto, R Bloigu, U Heiskanen, P Pääkkö VL Kinnula, R Kaarteenaho-Wiik, Thorax 2006 61 1091 1095 16769713 10.1136/thx.2005.055814 (Pubitemid 44852029)
34. Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis. P Rangappa, JL Moran, Crit Care Resusc 2009 11 102 109 19485873
35. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis. ER Fernández Pérez, CE Daniels, DR Schroeder, J St Sauver, TE Hartman, BJ Bartholmai, ES Yi, JH Ryu, Chest 2010 137 129 137 19749005 10.1378/chest.09-1002
36. Classification and natural history of the idiopathic interstitial pneumonias. DS Kim, HR Collard, TE King Jr, Proc Am Thorac Soc 2006 3 285 292 16738191 10.1513/pats.200601-005TK (Pubitemid 43845404)
37. Recent advances in idiopathic pulmonary fibrosis. I Noth, FJ Martinez, Chest 2007 132 637 650 17699135 10.1378/chest.06-1927 (Pubitemid 47282399)
38. An algorithm to tackle acute exacerbations in idiopathic pulmonary fibrosis. WA Wuyts, M Thomeer, LJ Dupont, GM Verleden, Am J Respir Crit Care Med 2008 177 1397 18522954 (Pubitemid 351860919)
39. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. RJ Panos, RL Mortenson, SA Niccoli, TE King, Am J Med 1990 88 396 404 2183601 10.1016/0002-9343(90)90495-Y (Pubitemid 20147276)
40. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. JJ Egan, JP Stewart, PS Hasleton, JR Arrand, KB Carroll, AA Woodcock, Thorax 1995 50 1234 1239 8553293 10.1136/thx.50.12.1234
41. Determinants of initiation and progression of idiopathic pulmonary fibrosis. RM Kottmann, CM Hogan, RP Phipps, PJ Sime, Respirology 2009 14 917 933 19740254 10.1111/j.1440-1843.2009.01624.x
42. Latent herpesvirus infection augments experimental pulmonary fibrosis. KM Vannella, TR Luckhardt, CA Wilke, LF van Dyk, GB Toews, BB Moore, Am J Respir Crit Care Med 2010 181 465 477 20185751 10.1164/rccm.200905-0798OC
43. Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter. AL Olson, JJ Swigris, G Raghu, KK Brown, Chest 2009 136 16 22 18689582 10.1378/chest.08-0703
44. Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. TR McMillan, BB Moore, JB Weinberg, KM Vannella, WB Fields, PJ Christensen, LF van Dyk, GB Toews, Am J Respir Crit Care Med 2008 177 771 780 18187693 10.1164/rccm.200708-1184OC (Pubitemid 351490564)
45. Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFbeta1 expression. AP Malizia, DT Keating, SM Smith, D Walls, PP Doran, JJ Egan, Am J Physiol Lung Cell Mol Physiol 2008 295 451 60 18621908 10.1152/ajplung.00376.2007
46. Acute lung injury and the acute respiratory distress syndrome: a clinical review. AP Wheeler, GR Bernard, Lancet 2007 369 1553 1565 17482987 10.1016/S0140-6736(07)60604-7 (Pubitemid 46670280)
47. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. MW Ziegenhagen, P Zabel, G Zissel, M Schlaak, J Müller-Quernheim, Am J Respir Crit Care Med 1998 157 762 768 9517588
48. Expression of alpha-defensins in the lungs and peripheral blood of patients with acute exacerbations of idiopathic pulmonary fibrosis [abstract]. K Konishi, KF Gibson, TJ Richards, KO Lindell, LJ Chensny, Y Zhang, N Kaminski, DS Kim, Am J Respir Crit Care Med 2009 179 3020
49. Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis. JJ Swigris, KK Brown, Semin Respir Crit Care Med 2006 27 659 667 17195142 10.1055/s-2006-957337 (Pubitemid 46048045)
50. Acute interstitial pneumonia. D Bouros, AC Nicholson, V Polychronopoulos, RM du Bois, Eur Respir J 2000 15 412 418 10706513 10.1034/j.1399-3003.2000. 15b31.x (Pubitemid 30085974)
51. The role of apoptosis in acute lung injury. TR Martin, M Nakamura, G Matute-Bello, Crit Care Med 2003 31 SUPPL. 4 184 S188 10.1097/01.CCM.0000057841. 33876.B1
52. Science review: apoptosis in acute lung injury. G Matute-Bello, TR Martin, Crit Care 2003 7 355 358 12974968 10.1186/cc1861 (Pubitemid 37236306)
53. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. GR Bernard, A Artigas, KL Brigham, J Carlet, K Falke, L Hudson, M Lamy, JR Legall, A Morris, R Spragg, Am J Respir Crit Care Med 1994 149 818 824 7509706 (Pubitemid 24082248)
54. Immunosuppression related to collagen-vascular disease or its treatment. CD Hamilton, Proc Am Thorac Soc 2005 2 456 460 16322600 10.1513/pats.200508- 091JS (Pubitemid 43128043)
55. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. GE Tzelepis, SP Toya, HM Moutsopoulos, Eur Respir J 2008 31 11 20 18166591 10.1183/09031936.00060107
56. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. M Akira, T Kozuka, S Yamamoto, M Sakatani, Am J Respir Crit Care Med 2008 178 372 378 18451320 10.1164/rccm.200709-1365OC
57. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. CI Silva, NL Müller, K Fujimoto, S Kato, K Ichikado, H Taniguchi, Y Kondoh, T Johkoh, A Churg, J Thorac Imaging 2007 22 221 229 17721330 10.1097/01.rti.0000213588.52343.13 (Pubitemid 47329825)
58. Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit. G Bertolini, M Confalonieri, C Rossi, G Rossi, B Simini, M Gorini, A Corrado, GiViTI (Gruppo italiano per la Valutazione degli interventi in Terapia Intensiva) Group; Aipo (Associazione Italiana Pneumologi Ospedalieri) Group, Respir Med 2005 99 894 900 15939252 10.1016/j.rmed.2004.11.014 (Pubitemid 40796565)
59. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. C Mollica, G Paone, V Conti, D Ceccarelli, G Schmid, P Mattia, N Perrone, A Petroianni, A Sebastiani, L Cecchini, R Orsetti, C Terzano, Respiration 2010 79 209 215 19546508 10.1159/000225932
60. Corticosteroids for idiopathic pulmonary fibrosis. L Richeldi, HR Davies, G Ferrara, F Franco, Cochrane Database Syst Rev 2003 3 D002880 12917934
61. Immunomodulatory agents for idiopathic pulmonary fibrosis. HR Davies, L Richeldi, EH Walters, Cochrane Database Syst Rev 2003 3 D003134 12917947
62. The Registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report-2003. EP Trulock, LB Edwards, DO Taylor, MM Boucek, PJ Mohacsi, BM Keck, MI Hertz, J Heart Lung Transplant 2003 22 625 635 12821160 10.1016/S1053- 2498(03)00182-7 (Pubitemid 36773675)
63. Respiratory intermediate care units: a European survey. A Corrado, C Roussos, N Ambrosino, M Confalonieri, A Cuvelier, M Elliott, M Ferrer, M Gorini, O Gurkan, JF Muir, L Quareni, D Robert, D Rodenstein, A Rossi, B Schoenhofer, AK Simonds, K Strom, A Torres, S Zakynthinos, European Respiratory Society Task Force on epidemiology of respiratory intermediate care in Europe, Eur Respir J 2002 20 1343 1350 12449191 10.1183/09031936.02.00302602 (Pubitemid 34822943)
64. Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. E Fernández-Pérez, M Yilmaz, H Jenad, C Daniels, J Ryu, R Hubmayr, O Gajic, Chest 2008 133 1113 1119 17989156 10.1378/chest.07-1481 (Pubitemid 351685514)
65. Linking parenchymal disease progression to changes in lung mechanical function by percolation. JH Bates, GS Davis, A Majumdar, KJ Butnor, B Suki, Am J Respir Crit Care Med 2007 176 617 623 17575096 10.1164/rccm.200611-1739OC (Pubitemid 47403280)
66. Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury. I Tsangaris, ME Lekka, E Kitsiouli, S Constantopoulos, G Nakos, Eur Respir J 2003 21 495 501 12662008 10.1183/09031936.03.00037902 (Pubitemid 36336211)
67. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. RM Determann, A Royakkers, EK Wolthuis, AP Vlaar, G Choi, F Paulus, JJ Hofstra, MJ de Graaff, JC Korevaar, MJ Schultz, Crit Care 2010 14 1 20055989 10.1186/cc8230
68. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network, N Engl J Med 2000 342 1301 1307 10793162 10.1056/NEJM200005043421801 (Pubitemid 30408714)
69. Effect of the prone position on patients with hydrostatic pulmonary edema compared with patients with acute respiratory distress syndrome and pulmonary fibrosis. G Nakos, I Tsangaris, E Kostanti, C Nathanail, A Lachana, V Koulouras, D Kastani, Am J Respir Crit Care Med 2000 161 360 368 10673172 (Pubitemid 30129439)
70. Low tidal volume, high respiratory rate and auto-PEEP: the importance of the basics. N Patroniti, A Pesenti, Crit Care 2003 7 105 106 12720551 10.1186/cc1883 (Pubitemid 36432663)
71. Extracorporeal membrane oxygenation for severe acute respiratory failure. K Lewandowski, Crit Care 2000 4 156 168 11094500 10.1186/cc689 (Pubitemid 30368048)
72. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. GJ Peek, M Mugford, R Tiruvoipati, A Wilson, E Allen, MM Thalanany, CL Hibbert, A Truesdale, F Clemens, N Cooper, RK Firmin, D Elbourne, CESAR trial collaboration, Lancet 2009 374 1351 1363 19762075 10.1016/S0140-6736(09)61069-2
73. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. M Zimmermann, T Bein, M Arlt, A Philipp, L Rupprecht, T Mueller, M Lubnow, BM Graf, HJ Schlitt, Crit Care 2009 13 10 19183475 10.1186/cc7703
74. Use of venovenous extracorporeal membrane oxygenation as a bridge to urgent lung transplantation in a case of acute respiratory failure. L Santambrogio, M Nosotti, A Palleschi, D Tosi, P Mendogni, A Lissoni, F Blasi, L Rosso, Transplant Proc 2009 41 1345 1346 19460555 10.1016/j.transproceed.2009. 02.065
75. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the pulmonary scientific council of the International Society for Heart and Lung Transplantation. JB Orens, M Estenne, S Arcasoy, JV Conte, P Corris, JJ Egan, T Egan, S Keshavjee, C Knoop, R Kotloff, FJ Martinez, S Nathan, S Palmer, A Patterson, L Singer, G Snell, S Studer, JL Vachiery, AR Glanville, J Heart Lung Transplant 2006 25 745 755 16818116 10.1016/j.healun.2006.03.011 (Pubitemid 43963375)